nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP2D6—Lomustine—brain cancer	0.138	0.282	CbGbCtD
Methotrimeprazine—CYP1A2—Carmustine—brain cancer	0.137	0.279	CbGbCtD
Methotrimeprazine—CYP2D6—Hydroxyurea—brain cancer	0.105	0.214	CbGbCtD
Methotrimeprazine—CYP2E1—Etoposide—brain cancer	0.0701	0.143	CbGbCtD
Methotrimeprazine—CYP1A2—Etoposide—brain cancer	0.0405	0.0827	CbGbCtD
Methotrimeprazine—HTR2C—choroid plexus—brain cancer	0.0279	0.0888	CbGeAlD
Methotrimeprazine—DRD3—telencephalic ventricle—brain cancer	0.0147	0.0468	CbGeAlD
Methotrimeprazine—HTR2A—choroid plexus—brain cancer	0.014	0.0445	CbGeAlD
Methotrimeprazine—HRH1—nose—brain cancer	0.0108	0.0344	CbGeAlD
Methotrimeprazine—DRD1—telencephalic ventricle—brain cancer	0.0105	0.0335	CbGeAlD
Methotrimeprazine—DRD5—ganglion—brain cancer	0.00857	0.0273	CbGeAlD
Methotrimeprazine—HTR2C—telencephalic ventricle—brain cancer	0.00817	0.026	CbGeAlD
Methotrimeprazine—HTR2A—trigeminal nerve—brain cancer	0.00707	0.0225	CbGeAlD
Methotrimeprazine—HTR2A—cerebellar cortex—brain cancer	0.00704	0.0224	CbGeAlD
Methotrimeprazine—DRD1—ganglion—brain cancer	0.00655	0.0208	CbGeAlD
Methotrimeprazine—HTR2A—vein—brain cancer	0.00639	0.0204	CbGeAlD
Methotrimeprazine—DRD2—telencephalic ventricle—brain cancer	0.00621	0.0198	CbGeAlD
Methotrimeprazine—Trifluoperazine—S100A4—brain cancer	0.00612	0.506	CrCbGaD
Methotrimeprazine—HTR2C—ganglion—brain cancer	0.00508	0.0162	CbGeAlD
Methotrimeprazine—HTR2A—cranial nerve—brain cancer	0.00504	0.016	CbGeAlD
Methotrimeprazine—HTR2A—pons—brain cancer	0.00498	0.0159	CbGeAlD
Methotrimeprazine—HTR2A—telencephalic ventricle—brain cancer	0.0041	0.013	CbGeAlD
Methotrimeprazine—DRD2—ganglion—brain cancer	0.00387	0.0123	CbGeAlD
Methotrimeprazine—HTR2A—pineal body—brain cancer	0.00355	0.0113	CbGeAlD
Methotrimeprazine—DRD5—telencephalon—brain cancer	0.0033	0.0105	CbGeAlD
Methotrimeprazine—ADRA1A—hindbrain—brain cancer	0.00299	0.00953	CbGeAlD
Methotrimeprazine—DRD2—hindbrain—brain cancer	0.00293	0.00934	CbGeAlD
Methotrimeprazine—DRD1—brainstem—brain cancer	0.00285	0.00906	CbGeAlD
Methotrimeprazine—ADRA1D—telencephalon—brain cancer	0.00265	0.00844	CbGeAlD
Methotrimeprazine—HTR2A—ganglion—brain cancer	0.00255	0.00812	CbGeAlD
Methotrimeprazine—DRD1—telencephalon—brain cancer	0.00253	0.00804	CbGeAlD
Methotrimeprazine—CHRM4—head—brain cancer	0.00236	0.00752	CbGeAlD
Methotrimeprazine—DRD4—brain—brain cancer	0.00226	0.00721	CbGeAlD
Methotrimeprazine—HTR2C—brainstem—brain cancer	0.00221	0.00704	CbGeAlD
Methotrimeprazine—HTR2A—endothelium—brain cancer	0.0022	0.007	CbGeAlD
Methotrimeprazine—DRD3—head—brain cancer	0.0022	0.00699	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—brain cancer	0.00216	0.00686	CbGeAlD
Methotrimeprazine—DRD5—endocrine gland—brain cancer	0.00208	0.00664	CbGeAlD
Methotrimeprazine—DRD5—head—brain cancer	0.00206	0.00655	CbGeAlD
Methotrimeprazine—CHRM2—telencephalon—brain cancer	0.00204	0.00648	CbGeAlD
Methotrimeprazine—HTR2A—blood vessel—brain cancer	0.00203	0.00646	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—brain cancer	0.002	0.00638	CbGeAlD
Methotrimeprazine—HTR2C—telencephalon—brain cancer	0.00196	0.00625	CbGeAlD
Methotrimeprazine—HTR2A—hindbrain—brain cancer	0.00193	0.00616	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—brain cancer	0.00188	0.00598	CbGeAlD
Methotrimeprazine—CHRM1—telencephalon—brain cancer	0.00185	0.0059	CbGeAlD
Methotrimeprazine—CHRM5—head—brain cancer	0.00185	0.00588	CbGeAlD
Methotrimeprazine—DRD1—midbrain—brain cancer	0.00181	0.00577	CbGeAlD
Methotrimeprazine—CYP2D6—hindbrain—brain cancer	0.00176	0.00561	CbGeAlD
Methotrimeprazine—ADRA1A—brainstem—brain cancer	0.00171	0.00546	CbGeAlD
Methotrimeprazine—CHRM4—brain—brain cancer	0.00171	0.00545	CbGeAlD
Methotrimeprazine—ADRA1B—head—brain cancer	0.00169	0.00537	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—brain cancer	0.00169	0.00537	CbGeAlD
Methotrimeprazine—DRD2—brainstem—brain cancer	0.00168	0.00535	CbGeAlD
Methotrimeprazine—ADRA1D—endocrine gland—brain cancer	0.00167	0.00532	CbGeAlD
Methotrimeprazine—CHRM3—telencephalon—brain cancer	0.00166	0.00528	CbGeAlD
Methotrimeprazine—ADRA1D—head—brain cancer	0.00165	0.00525	CbGeAlD
Methotrimeprazine—DRD3—brain—brain cancer	0.00159	0.00507	CbGeAlD
Methotrimeprazine—Diltiazem—CYP2C9—brain cancer	0.00159	0.131	CrCbGaD
Methotrimeprazine—DRD1—head—brain cancer	0.00157	0.00501	CbGeAlD
Methotrimeprazine—HTR2C—medulla oblongata—brain cancer	0.00154	0.00491	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—brain cancer	0.00154	0.0049	CbGeAlD
Methotrimeprazine—ADRA1A—telencephalon—brain cancer	0.00152	0.00485	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—brain cancer	0.00151	0.0048	CbGeAlD
Methotrimeprazine—DRD2—telencephalon—brain cancer	0.00149	0.00475	CbGeAlD
Methotrimeprazine—DRD5—brain—brain cancer	0.00149	0.00475	CbGeAlD
Methotrimeprazine—ADRA2C—telencephalon—brain cancer	0.00145	0.00462	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—brain cancer	0.00144	0.00457	CbGeAlD
Methotrimeprazine—HTR2C—midbrain—brain cancer	0.00141	0.00449	CbGeAlD
Methotrimeprazine—HTR2C—spinal cord—brain cancer	0.00137	0.00438	CbGeAlD
Methotrimeprazine—CHRM5—brain—brain cancer	0.00134	0.00426	CbGeAlD
Methotrimeprazine—CHRM2—endocrine gland—brain cancer	0.00128	0.00409	CbGeAlD
Methotrimeprazine—CHRM2—head—brain cancer	0.00127	0.00403	CbGeAlD
Methotrimeprazine—ADRA1B—brain—brain cancer	0.00122	0.00389	CbGeAlD
Methotrimeprazine—HTR2C—head—brain cancer	0.00122	0.00389	CbGeAlD
Methotrimeprazine—DRD2—pituitary gland—brain cancer	0.00121	0.00387	CbGeAlD
Methotrimeprazine—ADRA1D—brain—brain cancer	0.0012	0.00381	CbGeAlD
Methotrimeprazine—ADRA2C—pituitary gland—brain cancer	0.00118	0.00376	CbGeAlD
Methotrimeprazine—HRH1—telencephalon—brain cancer	0.00118	0.00375	CbGeAlD
Methotrimeprazine—CHRM1—endocrine gland—brain cancer	0.00117	0.00372	CbGeAlD
Methotrimeprazine—ADRA2A—telencephalon—brain cancer	0.00116	0.00368	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—brain cancer	0.00116	0.00368	CbGeAlD
Methotrimeprazine—CHRM1—head—brain cancer	0.00115	0.00367	CbGeAlD
Methotrimeprazine—ADRA2C—medulla oblongata—brain cancer	0.00114	0.00363	CbGeAlD
Methotrimeprazine—DRD1—brain—brain cancer	0.00114	0.00363	CbGeAlD
Methotrimeprazine—CYP2E1—telencephalon—brain cancer	0.00113	0.0036	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—brain cancer	0.00111	0.00355	CbGeAlD
Methotrimeprazine—HTR2A—brainstem—brain cancer	0.00111	0.00353	CbGeAlD
Methotrimeprazine—DRD2—midbrain—brain cancer	0.00107	0.00341	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—brain cancer	0.00105	0.00335	CbGeAlD
Methotrimeprazine—CHRM3—endocrine gland—brain cancer	0.00105	0.00333	CbGeAlD
Methotrimeprazine—ADRA2C—midbrain—brain cancer	0.00104	0.00332	CbGeAlD
Methotrimeprazine—CHRM3—head—brain cancer	0.00103	0.00329	CbGeAlD
Methotrimeprazine—ADRA2C—spinal cord—brain cancer	0.00102	0.00324	CbGeAlD
Methotrimeprazine—CYP2D6—brainstem—brain cancer	0.00101	0.00322	CbGeAlD
Methotrimeprazine—HTR2A—telencephalon—brain cancer	0.000984	0.00313	CbGeAlD
Methotrimeprazine—ADRA2A—gonad—brain cancer	0.000966	0.00308	CbGeAlD
Methotrimeprazine—ADRA1A—endocrine gland—brain cancer	0.00096	0.00306	CbGeAlD
Methotrimeprazine—ADRA1A—head—brain cancer	0.000948	0.00302	CbGeAlD
Methotrimeprazine—ADRA2A—pituitary gland—brain cancer	0.000942	0.003	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—brain cancer	0.000942	0.003	CbGeAlD
Methotrimeprazine—DRD2—endocrine gland—brain cancer	0.000941	0.003	CbGeAlD
Methotrimeprazine—Thioridazine—CYP2C9—brain cancer	0.000938	0.0776	CrCbGaD
Methotrimeprazine—DRD2—head—brain cancer	0.000929	0.00296	CbGeAlD
Methotrimeprazine—CHRM2—brain—brain cancer	0.000918	0.00292	CbGeAlD
Methotrimeprazine—Trimipramine—CYP2C9—brain cancer	0.000916	0.0758	CrCbGaD
Methotrimeprazine—ADRA2A—medulla oblongata—brain cancer	0.000909	0.0029	CbGeAlD
Methotrimeprazine—ADRA2C—head—brain cancer	0.000903	0.00288	CbGeAlD
Methotrimeprazine—CYP2D6—telencephalon—brain cancer	0.000896	0.00285	CbGeAlD
Methotrimeprazine—CYP2E1—medulla oblongata—brain cancer	0.00089	0.00283	CbGeAlD
Methotrimeprazine—HTR2C—brain—brain cancer	0.000885	0.00282	CbGeAlD
Methotrimeprazine—Promethazine—CYP2C9—brain cancer	0.000882	0.073	CrCbGaD
Methotrimeprazine—ADRA1A—central nervous system—brain cancer	0.000865	0.00275	CbGeAlD
Methotrimeprazine—Perphenazine—CYP2C9—brain cancer	0.000861	0.0713	CrCbGaD
Methotrimeprazine—DRD2—central nervous system—brain cancer	0.000848	0.0027	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—brain cancer	0.000846	0.00269	CbGeAlD
Methotrimeprazine—CHRM1—brain—brain cancer	0.000836	0.00266	CbGeAlD
Methotrimeprazine—ADRA2A—midbrain—brain cancer	0.000831	0.00265	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—brain cancer	0.000829	0.00264	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—brain cancer	0.000824	0.00262	CbGeAlD
Methotrimeprazine—HTR2A—gonad—brain cancer	0.000821	0.00261	CbGeAlD
Methotrimeprazine—ADRA2A—spinal cord—brain cancer	0.000811	0.00258	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—brain cancer	0.000806	0.00257	CbGeAlD
Methotrimeprazine—HTR2A—pituitary gland—brain cancer	0.000801	0.00255	CbGeAlD
Methotrimeprazine—CYP1A2—endocrine gland—brain cancer	0.000794	0.00253	CbGeAlD
Methotrimeprazine—CYP2E1—spinal cord—brain cancer	0.000793	0.00253	CbGeAlD
Methotrimeprazine—Promazine—CYP2C9—brain cancer	0.000776	0.0642	CrCbGaD
Methotrimeprazine—HTR2A—medulla oblongata—brain cancer	0.000773	0.00246	CbGeAlD
Methotrimeprazine—CHRM3—brain—brain cancer	0.000748	0.00238	CbGeAlD
Methotrimeprazine—HRH1—endocrine gland—brain cancer	0.000743	0.00237	CbGeAlD
Methotrimeprazine—HRH1—head—brain cancer	0.000734	0.00234	CbGeAlD
Methotrimeprazine—ADRA2A—endocrine gland—brain cancer	0.00073	0.00232	CbGeAlD
Methotrimeprazine—ADRA2A—head—brain cancer	0.000721	0.00229	CbGeAlD
Methotrimeprazine—CYP2E1—endocrine gland—brain cancer	0.000714	0.00227	CbGeAlD
Methotrimeprazine—HTR2A—midbrain—brain cancer	0.000707	0.00225	CbGeAlD
Methotrimeprazine—CYP2E1—head—brain cancer	0.000705	0.00224	CbGeAlD
Methotrimeprazine—HTR2A—spinal cord—brain cancer	0.000689	0.0022	CbGeAlD
Methotrimeprazine—ADRA1A—brain—brain cancer	0.000687	0.00219	CbGeAlD
Methotrimeprazine—DRD2—brain—brain cancer	0.000673	0.00214	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—brain cancer	0.00067	0.00213	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—brain cancer	0.000658	0.00209	CbGeAlD
Methotrimeprazine—ADRA2C—brain—brain cancer	0.000654	0.00208	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—brain cancer	0.000643	0.00205	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—brain cancer	0.000643	0.00205	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—brain cancer	0.000629	0.002	CbGeAlD
Methotrimeprazine—HTR2A—endocrine gland—brain cancer	0.000621	0.00198	CbGeAlD
Methotrimeprazine—HTR2A—head—brain cancer	0.000613	0.00195	CbGeAlD
Methotrimeprazine—CYP2D6—endocrine gland—brain cancer	0.000565	0.0018	CbGeAlD
Methotrimeprazine—HTR2A—central nervous system—brain cancer	0.000559	0.00178	CbGeAlD
Methotrimeprazine—CYP2D6—head—brain cancer	0.000558	0.00178	CbGeAlD
Methotrimeprazine—HTR2A—cerebellum—brain cancer	0.000547	0.00174	CbGeAlD
Methotrimeprazine—HRH1—brain—brain cancer	0.000532	0.00169	CbGeAlD
Methotrimeprazine—ADRA2A—brain—brain cancer	0.000522	0.00166	CbGeAlD
Methotrimeprazine—CYP2E1—brain—brain cancer	0.000511	0.00163	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—brain cancer	0.00051	0.00162	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—brain cancer	0.000498	0.00159	CbGeAlD
Methotrimeprazine—HTR2A—brain—brain cancer	0.000444	0.00141	CbGeAlD
Methotrimeprazine—CYP2D6—brain—brain cancer	0.000404	0.00129	CbGeAlD
Methotrimeprazine—DRD1—Signaling by GPCR—EGFR—brain cancer	2.42e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SPP1—brain cancer	2.42e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—brain cancer	2.39e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—VEGFA—brain cancer	2.39e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL2—brain cancer	2.39e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	2.39e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—EGFR—brain cancer	2.39e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—STAT3—brain cancer	2.37e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—APC—brain cancer	2.37e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	2.37e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	2.36e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL2—brain cancer	2.35e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL2—brain cancer	2.35e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CG—brain cancer	2.34e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL2—brain cancer	2.34e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL2—brain cancer	2.33e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	2.32e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL2—brain cancer	2.31e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—RELA—brain cancer	2.31e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL2—brain cancer	2.3e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—ERBB2—brain cancer	2.29e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—RELA—brain cancer	2.28e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	2.27e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—APC—brain cancer	2.27e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IRS2—brain cancer	2.27e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—ERBB2—brain cancer	2.26e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SPP1—brain cancer	2.25e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IRS2—brain cancer	2.24e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IRS2—brain cancer	2.23e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IRS2—brain cancer	2.22e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IRS2—brain cancer	2.22e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—APC—brain cancer	2.21e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	2.21e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MYC—brain cancer	2.2e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IRS2—brain cancer	2.19e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IRS2—brain cancer	2.19e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—RELA—brain cancer	2.18e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—APC—brain cancer	2.18e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	2.18e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—ERBB2—brain cancer	2.17e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	2.16e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—EGFR—brain cancer	2.15e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CG—brain cancer	2.15e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL2—brain cancer	2.14e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL2—brain cancer	2.08e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—RELA—brain cancer	2.08e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—EGFR—brain cancer	2.07e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—ERBB2—brain cancer	2.06e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL2—brain cancer	2.05e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—RELA—brain cancer	2.05e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—RELA—brain cancer	2.05e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	2.04e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—ERBB2—brain cancer	2.04e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IRS2—brain cancer	2.03e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CCND1—brain cancer	2.02e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	2.01e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CG—brain cancer	2.01e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—APC—brain cancer	2.01e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CTNNB1—brain cancer	2.01e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CCND1—brain cancer	2e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.98e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.98e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—APC—brain cancer	1.97e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.97e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CG—brain cancer	1.97e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—APC—brain cancer	1.97e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.97e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.96e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APC—brain cancer	1.96e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL2—brain cancer	1.96e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APC—brain cancer	1.96e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	1.96e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APC—brain cancer	1.94e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.94e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.93e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APC—brain cancer	1.93e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CCND1—brain cancer	1.91e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	1.89e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL2—brain cancer	1.87e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—RELA—brain cancer	1.85e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL2—brain cancer	1.84e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL2—brain cancer	1.84e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.84e-05	0.0001	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.83e-05	9.96e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CCND1—brain cancer	1.82e-05	9.94e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—brain cancer	1.81e-05	9.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CTNNB1—brain cancer	1.81e-05	9.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.8e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CCND1—brain cancer	1.8e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.8e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APC—brain cancer	1.8e-05	9.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.8e-05	9.79e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—EGFR—brain cancer	1.79e-05	9.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—EGFR—brain cancer	1.79e-05	9.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—EGFR—brain cancer	1.78e-05	9.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.78e-05	9.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.78e-05	9.71e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—RELA—brain cancer	1.78e-05	9.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—EGFR—brain cancer	1.77e-05	9.62e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—VEGFA—brain cancer	1.77e-05	9.62e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.77e-05	9.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.76e-05	9.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—STAT3—brain cancer	1.75e-05	9.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—VEGFA—brain cancer	1.74e-05	9.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—RELA—brain cancer	1.73e-05	9.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—STAT3—brain cancer	1.72e-05	9.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	1.72e-05	9.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—RELA—brain cancer	1.7e-05	9.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.69e-05	9.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—VEGFA—brain cancer	1.67e-05	9.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL2—brain cancer	1.67e-05	9.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—STAT3—brain cancer	1.65e-05	9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.64e-05	8.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MYC—brain cancer	1.62e-05	8.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CCND1—brain cancer	1.62e-05	8.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	1.61e-05	8.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MYC—brain cancer	1.6e-05	8.73e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL2—brain cancer	1.6e-05	8.72e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—brain cancer	1.59e-05	8.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EGFR—brain cancer	1.59e-05	8.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—STAT3—brain cancer	1.57e-05	8.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.57e-05	8.55e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—brain cancer	1.57e-05	8.55e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—RELA—brain cancer	1.57e-05	8.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EGFR—brain cancer	1.57e-05	8.54e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCND1—brain cancer	1.56e-05	8.5e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—ERBB2—brain cancer	1.56e-05	8.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL2—brain cancer	1.56e-05	8.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.55e-05	8.46e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—STAT3—brain cancer	1.55e-05	8.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	1.54e-05	8.42e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—RELA—brain cancer	1.54e-05	8.41e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—RELA—brain cancer	1.54e-05	8.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MYC—brain cancer	1.53e-05	8.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—RELA—brain cancer	1.53e-05	8.36e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ERBB2—brain cancer	1.53e-05	8.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2—brain cancer	1.53e-05	8.35e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ERBB2—brain cancer	1.53e-05	8.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—RELA—brain cancer	1.53e-05	8.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ERBB2—brain cancer	1.52e-05	8.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ERBB2—brain cancer	1.52e-05	8.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCND1—brain cancer	1.52e-05	8.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—RELA—brain cancer	1.51e-05	8.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—RELA—brain cancer	1.51e-05	8.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ERBB2—brain cancer	1.5e-05	8.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	1.5e-05	8.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.5e-05	8.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EGFR—brain cancer	1.5e-05	8.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.49e-05	8.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.48e-05	8.06e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MYC—brain cancer	1.46e-05	7.97e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MYC—brain cancer	1.44e-05	7.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MYC—brain cancer	1.44e-05	7.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EGFR—brain cancer	1.43e-05	7.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	1.42e-05	7.72e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2—brain cancer	1.41e-05	7.69e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EGFR—brain cancer	1.41e-05	7.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.41e-05	7.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—RELA—brain cancer	1.4e-05	7.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—brain cancer	1.4e-05	7.64e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.4e-05	7.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.39e-05	7.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2—brain cancer	1.39e-05	7.57e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2—brain cancer	1.39e-05	7.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2—brain cancer	1.38e-05	7.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2—brain cancer	1.38e-05	7.51e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCND1—brain cancer	1.38e-05	7.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2—brain cancer	1.36e-05	7.43e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.36e-05	7.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2—brain cancer	1.36e-05	7.41e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.36e-05	7.41e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCND1—brain cancer	1.35e-05	7.38e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCND1—brain cancer	1.35e-05	7.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCND1—brain cancer	1.35e-05	7.34e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—brain cancer	1.35e-05	7.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCND1—brain cancer	1.34e-05	7.32e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.34e-05	7.31e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CTNNB1—brain cancer	1.34e-05	7.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	1.33e-05	7.27e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—brain cancer	1.33e-05	7.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCND1—brain cancer	1.33e-05	7.25e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	1.33e-05	7.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.33e-05	7.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	1.32e-05	7.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	1.32e-05	7.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—brain cancer	1.32e-05	7.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.31e-05	7.16e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—brain cancer	1.31e-05	7.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—brain cancer	1.3e-05	7.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.3e-05	7.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.29e-05	7.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.27e-05	6.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—brain cancer	1.26e-05	6.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—brain cancer	1.26e-05	6.87e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—brain cancer	1.25e-05	6.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.23e-05	6.72e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—brain cancer	1.22e-05	6.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.22e-05	6.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—brain cancer	1.22e-05	6.63e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—brain cancer	1.2e-05	6.54e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—brain cancer	1.2e-05	6.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—brain cancer	1.2e-05	6.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—brain cancer	1.19e-05	6.49e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—brain cancer	1.19e-05	6.48e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CG—brain cancer	1.19e-05	6.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—brain cancer	1.18e-05	6.46e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—brain cancer	1.18e-05	6.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—brain cancer	1.18e-05	6.43e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—brain cancer	1.18e-05	6.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—brain cancer	1.17e-05	6.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.17e-05	6.38e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—brain cancer	1.17e-05	6.38e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—brain cancer	1.17e-05	6.37e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—brain cancer	1.17e-05	6.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—brain cancer	1.16e-05	6.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—brain cancer	1.16e-05	6.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—brain cancer	1.16e-05	6.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.16e-05	6.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—brain cancer	1.15e-05	6.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.14e-05	6.24e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—brain cancer	1.1e-05	6.02e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—brain cancer	1.09e-05	5.92e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—brain cancer	1.08e-05	5.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—brain cancer	1.08e-05	5.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—brain cancer	1.08e-05	5.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—brain cancer	1.08e-05	5.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—brain cancer	1.07e-05	5.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—brain cancer	1.07e-05	5.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—brain cancer	1.06e-05	5.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—brain cancer	1.06e-05	5.8e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—brain cancer	1.06e-05	5.79e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—brain cancer	1.06e-05	5.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—brain cancer	1.06e-05	5.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—brain cancer	1.05e-05	5.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—brain cancer	1.04e-05	5.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.04e-05	5.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—brain cancer	1.03e-05	5.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—brain cancer	9.99e-06	5.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—brain cancer	9.88e-06	5.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—brain cancer	9.83e-06	5.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—brain cancer	9.67e-06	5.27e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—brain cancer	9.07e-06	4.94e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—brain cancer	8.92e-06	4.86e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—brain cancer	8.9e-06	4.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—brain cancer	8.87e-06	4.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—brain cancer	8.84e-06	4.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—brain cancer	8.76e-06	4.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—brain cancer	8.73e-06	4.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—brain cancer	8.12e-06	4.42e-05	CbGpPWpGaD
